Effects of Mobilization and Caffeine After Cesarean

February 5, 2026 updated by: Hafize Dağ Tüzmen, KTO Karatay University

The Effect of Early Post-Cesarean Mobilization and Caffeine Consumption on Bowel Motility, Pain, and Psychological Well-being: A Randomized Controlled Trial

This study Maims to assess bowel motility, pain and psychological well-being in women in the post-cesarean period by mobilizing them early and encouraging them to consume coffee.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

In the intervention group, the goal is to initiate bowel motility by mobilizing women early in the post-cesarean period. This increased bowel motility will facilitate gas expulsion, thus minimizing pain levels. Caffeine consumption will help keep pain levels at a minimum. By minimizing pain, women will experience positive psychological well-being.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
      • Konya, Turkey (Türkiye), 42208
        • Recruiting
        • KTO Karatay University
        • Contact:
        • Sub-Investigator:
          • Esma Kovalı, Yükseklisans Öğrencisi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Being between 18 and 35 years of age,
  2. Women who underwent cesarean delivery under spinal anesthesia,
  3. Having a post-cesarean pain level of 4 or higher,
  4. Being able to understand and write Turkish and communicate effectively with researchers.

Exclusion Criteria:

  1. Women who underwent emergency cesarean delivery,
  2. Those with pregnancy complications (preeclampsia, placenta previa, etc.),
  3. Those with a history of chronic gastrointestinal disease (e.g., irritable bowel syndrome, Crohn's disease, ulcerative colitis),
  4. Those with sensitivity or allergy to caffeine,
  5. Those with a history of chronic pain syndrome or dependence on analgesics,
  6. Regular coffee drinkers (≥2 cups per day),
  7. Intraoperative complications such as bowel or bladder injury,

i) Those who cannot comply with the study protocol or complete the follow-up process.

Removal Criteria:

  1. Participants are excluded from the study under the following conditions:
  2. During surgery If complications occur (e.g., bladder or bowel injury, excessive bleeding),
  3. Postoperative complications requiring admission to the intensive care unit (ICU) for the mother or newborn,
  4. Development of severe postoperative nausea, vomiting, or intolerance to oral intake,
  5. Inability to consume or refusal to consume coffee according to the study protocol,
  6. Withdrawal of consent by the participant at any point during the study,
  7. Failure to comply with surgical procedures or loss of follow-up,
  8. Development of medical conditions during follow-up that may affect study results (e.g., acute infections, neurological disorders).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control Group
Women in the control group will receive routine intervention. They will be mobilized at 6 hours. Decaffeinated coffee will be served at 6-hour intervals.
Dietary supplement: Decaffeinated coffee
The women in the control group will be mobilised at the 6-hour mark. The control group will be given decaffeinated Turkish coffee at 6-hour intervals.
Experimental: intervention group
They will be mobilized at 4 hours.They will consume Turkish coffee containing caffeine every six hours.
Dietary supplement: caffeine consumption
The women in the intervention group will be mobilised at the 4-hour mark. The intervention group will be given caffeinated Turkish coffee at 6-hour intervals.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in postoperative pain after caesarean section within 24 hours from baseline
Time Frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours
Pain will be assessed using a 10 cm visual analogue scale. '0' means no pain, while '10' means unbearable pain. The assessment will be carried out at the start of the study, at 6-hour intervals, and at the end.
Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours
Change in postoperative Bowel Motility after caesarean section within 24 hours from baseline
Time Frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours
Bowel motility will be assessed using BFI. The Bowel Function Index (BFI) is a short and practical measure used to assess constipation, particularly in patients using opioids. It consists of three questions, each scored on a scale of 0 to 100. These scores are used to measure the degree of bowel dysfunction.
Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours
Change in postoperative Psychological Well-being after caesarean section within 24 hours from baseline
Time Frame: Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours
Psychological Well-being will be assessed using Psychological Well-Being Scale. Based on the score obtained: 1.00-2.99 → Low psychological resilience, 3.00-4.30 → Moderate level, 4.31-5.00 → High psychological resilience.
Starting point, after intervention at 6 hours, 12 hours, 18 hours and 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

KTO Karatay University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 25, 2025

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

January 19, 2026

First Submitted That Met QC Criteria

January 19, 2026

First Posted (Actual)

January 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 9, 2026

Last Update Submitted That Met QC Criteria

February 5, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AIBU-EBE-EK-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Decaffeinated coffee

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe